NCT02198274View on ClinicalTrials.gov

Intravenous BIBH 1 in Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

October 31, 2000

Conditions
Colorectal Neoplasms
Interventions
DRUG

BIBH 1

100 mg/week

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02198274 - Intravenous BIBH 1 in Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter